Revvity

Revvity is a prominent player in the Test & Measurement Equipment and Manufacturing industries, providing advanced health science solutions, technologies, and specialized expertise. Founded in 2023, the company delivers integrated workflows that span the entire spectrum from scientific discovery and research to clinical development, diagnosis, and treatment. By offering specialized technologies, signal processing tools, and high-quality reagents, Revvity supports researchers and clinicians in accelerating innovation and improving patient care outcomes on a global scale.

Operating with over 10,000 employees, the organization maintains a robust international presence across 14 strategic locations. Learn about Revvity's global headquarters for detailed information regarding their primary operational footprint in Waltham, Massachusetts. The company’s sophisticated infrastructure is specifically designed to facilitate complex scientific workflows, ensuring that research organizations and clinical facilities can effectively manage the critical transition from initial laboratory research to final diagnostic application and patient treatment.

Publicly traded on the NYSE under the ticker RVTY, the company reports annual revenue of $2.9B and continues to expand its influence within the life sciences sector through strategic innovation. Meet Revvity's team to gain insights into the leadership, technical expertise, and professional talent driving their ongoing strategic initiatives. With a dedicated focus on high-impact health science, Revvity remains committed to advancing diagnostic capabilities and drug development, positioning itself as a critical partner for healthcare organizations seeking to enhance their operational efficiency and scientific output in an increasingly competitive global market.